Stocks to watch
Upgrades, downgrades, or major signals – these stocks are making waves.
The stock screener that catches what looks good but isn't.
Compare Health, Risk, Performance, and Trend on every stock, side by side.
Overall stock screener, find the best stocks at a glance. Rankings combine Stoxcraft Rating, Health, Performance, Risk, Trend and BuyMeter, so you see what matters first. Filter by sector, market cap or dividend, and check the Earnings Streak to spot stocks that consistently beat expectations.
| Symbol | Name | Rating | Price | Today | Health | Performance | Risk | Trend | BuyMeter | ESG Score | Earning Streak | Market Cap | Volume | P/E | Dividend | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OSCR
|
Oscar Health, Inc. | 29.60 USD | +2.53 % | 6.8 | Strong Buy | 56.30 | 7.67B | 5.38M | -9 | - | Healthcare | Medical - Healthcare Plans | |||||
|
AMRX
|
Amneal Pharmaceuticals, Inc. | 19.77 USD | -0.18 % | 4.9 | Buy | 64.47 | 6.31B | 2.04M | 55 | - | Healthcare | Drug Manufacturers - Specialty & Generic | |||||
|
ADMA
|
ADMA Biologics, Inc. | 9.38 USD | -1.47 % | 7.0 | Hold | 62.01 | 2.17B | 2.61M | 29 | - | Healthcare | Biotechnology | |||||
|
CON
|
Concentra Group Holdings Parent, Inc. | 35.01 USD | +1.13 % | 3.9 | Buy | 72.58 | 4.48B | 953,887 | 14 | 0.72 % | Healthcare | Medical - Care Facilities | |||||
|
HAE
|
Haemonetics Corporation | 105.30 USD | -0.66 % | 5.5 | Buy | 91.97 | 4.79B | 702,277 | 26 | - | Healthcare | Medical - Devices | |||||
|
HNGE
|
Hinge Health, Inc. | 95.57 USD | +3.90 % | 6.1 | Buy | 58.31 | 7.40B | 1.85M | -9 | - | Healthcare | Medical - Healthcare Information Services | |||||
|
TGTX
|
TG Therapeutics, Inc. | 57.43 USD | -0.16 % | 6.8 | Buy | 58.03 | 8.79B | 2.09M | 10 | - | Healthcare | Biotechnology | |||||
|
INVA
|
Innoviva, Inc. | 20.74 USD | +0.39 % | 2.9 | Strong Buy | 67.02 | 1.53B | 813,532 | 5 | - | Healthcare | Biotechnology | |||||
|
ONC
|
BeOne Medicines AG | 360.85 USD | +0.24 % | 3.8 | Buy | 58.69 | 38.56B | 387,870 | 183 | - | Healthcare | Biotechnology | |||||
|
PBYI
|
Puma Biotechnology, Inc. | 9.77 USD | -0.51 % | 6.0 | Strong Buy | 64.72 | 497.29M | 326,223 | 10 | - | Healthcare | Biotechnology | |||||
|
SEZL
|
Sezzle Inc. | 111.38 USD | +1.46 % | 10.0 | Hold | 75.69 | 3.75B | 642,319 | 16 | - | Financial Services | Financial - Credit Services | |||||
|
SKWD
|
Skyward Specialty Insurance Group, Inc. | 54.78 USD | -0.18 % | 4.7 | Buy | 63.31 | 2.22B | 503,280 | 12 | - | Financial Services | Insurance - Property & Casualty | |||||
|
FN
|
Fabrinet | 417.39 USD | +4.78 % | 8.2 | Buy | 68.21 | 14.95B | 866,168 | 32 | - | Technology | Hardware, Equipment & Parts | |||||
|
OFG
|
OFG Bancorp | 51.94 USD | +0.39 % | 3.3 | Strong Buy | 76.30 | 2.20B | 282,430 | 9 | 2.60 % | Financial Services | Banks - Regional | |||||
|
CUBI
|
Customers Bancorp, Inc. | 77.06 USD | +0.30 % | 3.0 | Buy | 64.05 | 2.61B | 285,749 | 11 | - | Financial Services | Banks - Regional | |||||
|
WABC
|
Westamerica Bancorporation | 60.67 USD | +1.37 % | 2.1 | Buy | 56.81 | 1.43B | 187,929 | 11 | 3.12 % | Financial Services | Banks - Regional | |||||
|
SAFT
|
Safety Insurance Group, Inc. | 103.51 USD | 0.00 % | 3.6 | Buy | 71.55 | 1.52B | 207,695 | 12 | 3.57 % | Financial Services | Insurance - Property & Casualty | |||||
|
BY
|
Byline Bancorp, Inc. | 37.44 USD | +0.89 % | 2.5 | Buy | 84.11 | 1.70B | 283,203 | 10 | 1.21 % | Financial Services | Banks - Regional | |||||
|
BANR
|
Banner Corporation | 69.03 USD | +0.35 % | 2.7 | Buy | 87.88 | 2.35B | 347,177 | 11 | 2.84 % | Financial Services | Banks - Regional | |||||
|
BOW
|
Bowhead Specialty Holdings Inc. | 33.76 USD | -0.32 % | 3.5 | Buy | 74.85 | 1.11B | 319,568 | 17 | - | Financial Services | Insurance - Property & Casualty | |||||
|
FBNC
|
First Bancorp | 63.50 USD | +1.11 % | 2.4 | Buy | 75.69 | 2.63B | 230,596 | 19 | 1.50 % | Financial Services | Banks - Regional | |||||
|
FCF
|
First Commonwealth Financial Corporation | 20.91 USD | -0.14 % | 2.3 | Buy | 83.40 | 2.13B | 825,655 | 11 | 2.56 % | Financial Services | Banks - Regional | |||||
|
FIHL
|
Fidelis Insurance Holdings Limited | 23.06 USD | -0.82 % | 2.3 | Strong Buy | 58.35 | 2.45B | 561,330 | 10 | 2.95 % | Financial Services | Insurance - Diversified | |||||
|
STEL
|
Stellar Bancorp, Inc. | 39.32 USD | +0.03 % | 2.1 | Buy | 69.81 | 2.00B | 466,994 | 16 | 1.54 % | Financial Services | Banks - Regional | |||||
|
OBK
|
Origin Bancorp, Inc. | 53.64 USD | +0.64 % | 2.3 | Buy | 72.25 | 1.66B | 166,484 | 15 | 1.47 % | Financial Services | Banks - Regional | |||||
|
UVSP
|
Univest Financial Corporation | 42.16 USD | +0.89 % | 2.2 | Buy | 74.15 | 1.16B | 237,258 | 10 | 2.03 % | Financial Services | Banks - Regional | |||||
|
OSBC
|
Old Second Bancorp, Inc. | 24.95 USD | +0.52 % | 3.1 | Buy | 78.43 | 1.28B | 429,533 | 12 | 1.11 % | Financial Services | Banks - Regional | |||||
|
HAFC
|
Hanmi Financial Corporation | 32.10 USD | +0.85 % | 3.6 | Buy | 86.05 | 955.50M | 238,016 | 11 | 3.47 % | Financial Services | Banks - Regional | |||||
|
OPY
|
Oppenheimer Holdings Inc. | 119.78 USD | +1.03 % | 4.4 | Buy | 61.29 | 1.27B | 124,758 | 5 | 1.51 % | Financial Services | Financial - Capital Markets | |||||
|
CAC
|
Camden National Corp. | 57.82 USD | +1.62 % | 2.5 | Buy | 60.48 | 978.01M | 95,488 | 11 | 3.10 % | Financial Services | Banks - Regional |
The stock screener that compares every stock to the right benchmark
Stoxcraft is a free stock screener, and it doesn't just dump numbers on you. On the Health tab, every fundamental metric is color coded against its sector average, so you see instantly whether a number is actually good, or just average dressed up as good. The Risk tab flips the comparison to the overall market instead of a sector. A calm balance sheet is a calm balance sheet, whether you're in Tech or Utilities.
No finance degree required. Dividend hunters can turn on Dividends Only and use this as a dedicated dividend stock screener, built to separate real payout safety from a headline yield. Day traders get the Trend tab instead, RSI and volume doing the real talking before a move even shows up in the price. And for anyone screening with a longer horizon, this doubles as a growth stock screener too: Revenue Growth 5Y sits right next to Income Growth 5Y, so you can tell a real compounder from one good quarter. Pick a tab, and know within seconds whether a stock deserves a second look.